1. CMU Intellectual Repository

Browsing by Author Rosie Mngqibisa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Jul-2020Distal sensory peripheral neuropathy in human immunodeficiency virus type 1-positive individuals before and after antiretroviral therapy initiation in diverse resource-limited settingsAlyssa C. Vecchio; Christina M. Marra; Jeffrey Schouten; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; James Hakim; Ned Sacktor; Thomas B. Campbell; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T. Silva; Cecilia Kanyama; Cindy Firnhaber; Mina C. Hosseinipour; Rosie Mngqibisa; Colin Hall; Paola Cinque; Kevin Robertson
1-Aug-2012Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational SettingsThomas B. Campbell; Laura M. Smeaton; N. Kumarasamy; Timothy Flanigan; Karin L. Klingman; Cynthia Firnhaber; Beatriz Grinsztejn; Mina C. Hosseinipour; Johnstone Kumwenda; Umesh Lalloo; Cynthia Riviere; Jorge Sanchez; Marineide Melo; Khuanchai Supparatpinyo; Srikanth Tripathy; Ana I. Martinez; Apsara Nair; Ann Walawander; Laura Moran; Yun Chen; Wendy Snowden; James F. Rooney; Jonathan Uy; Robert T. Schooley; Victor de Gruttola; James Gita Hakim; Edith Swann; Ronald L. Barnett; Barbara Brizz; Yvette Delph; Nikki Gettinger; Ronald T. Mitsuyasu; Susan Eshleman; Steven Safren; Susan A. Fiscus; Adriana Andrade; David W. Haas; Farida Amod; Vladimir Berthaud; Robert C. Bollinger; Yvonne Bryson; David Celentano; David Chilongozi; Myron Cohen; Ann C. Collier; Judith Silverstein Currier; Susan Cu-Uvin; Joseph Eron; Charles Flexner; Joel E. Gallant; Roy M. Gulick; Scott M. Hammer; Irving Hoffman; Peter Kazembe; Newton Kumwenda; Javier R. Lama; Jody Lawrence; Chiedza Maponga; Francis Martinson; Kenneth Mayer; Karin Nielsen; Richard B. Pendame; Bharat Ramratnam; Ian Sanne; Patrice Severe; Thira Sirisanthana; Suniti Solomon; Steve Tabet; Taha Taha; Charles van der Horst; Christine Wanke; Joan Gormley; Cheryl J. Marcus; Beverly Putnam; Smanga Ntshele; Edde Loeliger; Keith A. Pappa; Nancy Webb; David L. Shugarts; Mark A. Winters; Renard S. Descallar; Joseph Steele; Michael Wulfsohn; Farideh Said; Yue Chen; John C. Martin; Norbert Bischofberger; Andrew Cheng; Howard Jaffe; Jabin Sharma; S. Poongulali; Sandra Wagner Cardoso; Deise Lucia Faria; Sima Berendes; Kelly Burke; Rosie Mngqibisa; Cecelia Kanyama; Virginia Kayoyo; Wadzanai P. Samaneka; Anthony Chisada
1-May-2019Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited SettingsKevin R. Robertson; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; Christina M. Marra; Baiba Berzins; James Hakim; Ned Sacktor; Thomas B. Campbell; Jeffrey Schouten; Katie Mollan; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T. Silva; Cecilia Kanyama; Cindy Firhnhaber; Robert Murphy; Colin Hall; Cheryl Marcus; Linda Naini; Reena Masih; Mina C. Hosseinipour; Rosie Mngqibisa; Sharlaa Badal-Faesen; Sarah Yosief; Alyssa Vecchio; Apsara Nair
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
Showing results 1 to 5 of 5